Toward peptide-based inhibitors as therapies for Parkinson's disease

Jody M. Mason, David P. Fairlie

Research output: Contribution to journalEditorial

3 Citations (Scopus)
71 Downloads (Pure)
Original languageEnglish
Pages (from-to)2103-2105
JournalFuture Medicinal Chemistry
Volume7
Issue number16
Early online date29 Oct 2015
DOIs
Publication statusPublished - 2015

Keywords

  • alpha-synuclein
  • mimetics
  • drug design
  • Peptides
  • Parkinson's disease
  • amyloid

Cite this

Toward peptide-based inhibitors as therapies for Parkinson's disease. / Mason, Jody M.; Fairlie, David P.

In: Future Medicinal Chemistry, Vol. 7, No. 16, 2015, p. 2103-2105.

Research output: Contribution to journalEditorial

@article{2587325fc8de4bef841366c4006931b4,
title = "Toward peptide-based inhibitors as therapies for Parkinson's disease",
keywords = "alpha-synuclein, mimetics, drug design, Peptides, Parkinson's disease, amyloid",
author = "Mason, {Jody M.} and Fairlie, {David P.}",
year = "2015",
doi = "10.4155/fmc.15.139",
language = "English",
volume = "7",
pages = "2103--2105",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "16",

}

TY - JOUR

T1 - Toward peptide-based inhibitors as therapies for Parkinson's disease

AU - Mason, Jody M.

AU - Fairlie, David P.

PY - 2015

Y1 - 2015

KW - alpha-synuclein

KW - mimetics

KW - drug design

KW - Peptides

KW - Parkinson's disease

KW - amyloid

UR - http://dx.doi.org/10.4155/fmc.15.139

U2 - 10.4155/fmc.15.139

DO - 10.4155/fmc.15.139

M3 - Editorial

VL - 7

SP - 2103

EP - 2105

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 16

ER -